Actionable news
0
All posts from Actionable news
Actionable news in MACK: Merrimack Pharmaceuticals, Inc.,

Merrimack Pharmaceuticals Inc.

Average Recommendation: Buy Average Target Price: 13.75
Number of Ratings: 5 Current Quarters Estimate: -0.38
FY Report Date: 12 / 2016 Current Year's Estimate: -0.96
Last Quarter's Earnings: N/A Median PE on CY...

More